Table 1.
Adequate doses for selective serotonin receptor inhibitor (SSRI) and serotonin and noradrenaline receptor inhibitor (SNRI) antidepressants – table showing the list of adequate doses of SSRI/SNRI antidepressants used in the MIR study
| Name | Trade name | Type | BNFa Code | Minimum adequate daily dose (mg) |
|---|---|---|---|---|
| Citalopram | Cipramil | SSRI | 4.3.3 | 20 |
| Duloxetine | Cymbalta/ Yentreve | SNRI | 4.3.4 | 60 |
| Escitalopram | Cipralex | SSRI | 4.3.3 | 10 |
| Fluoxetine | Prozac | SSRI | 4.3.3 | 20 |
| Fluvoxamine | Faverin | SSRI | 4.3.3 | 100 |
| Paroxetine | Seroxat | SSRI | 4.3.3 | 20 |
| Sertraline | Lustral | SSRI | 4.3.3 | 100 |
| Venlafazine | Effexor | SNRI | 4.3.4 | 75 |
aSource: British National Formulary (BNF) No.55 (March 2008) for BNF code and dosage. These minimum doses were chosen to reflect prescribing guidance in UK primary care, and with expert advice from psychopharmacologists